Bare Financial Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.86K Hold
46
– – ﹤0.01% 674
2026
Q2
$3.22K Sell
46
-16
-26% -$828 ﹤0.01% 1006
2026
Q1
$3.15K Buy
62
+16
+35% +$746 ﹤0.01% 830
2025
Q4
$1.36K Buy
+46
New +$1.25K ﹤0.01% 1007

Other funds holding MRNA

Bare Financial Services's MRNA Position: Q3 2026 in Review

Bare Financial Services held its Moderna (MRNA) position steady in Q3 2026 at 46 shares worth $8.86K. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Bare Financial Services first reported a position in MRNA in Q4 2025 and has held it in 4 quarters since. 573 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Bare Financial Services held 46 shares of Moderna worth $8.86K as of Q3 2026.
  • Bare Financial Services left its Moderna share count unchanged in Q3 2026.
  • Moderna made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #674 holding.
  • Bare Financial Services first reported a position in Moderna in Q4 2025 and has held it in 4 quarters since.
  • 573 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.